Voors AA - Search Results

1

Effect of isolated ultrafiltration and isovolemic dialysis on myocardial perfusion and left ventricular function assessed with ¹³N-NH₃ positron emission tomography and echocardiography.

Assa S, Kuipers J, Ettema E, Gaillard CAJM, Krijnen WP, Hummel YM, Voors AA, van Melle JP, Westerhuis R, Willemsen A, Slart RHJA, Franssen CFM. Assa S, et al. Among authors: voors aa. Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F445-F452. doi: 10.1152/ajprenal.00368.2017. Epub 2017 Nov 8. Am J Physiol Renal Physiol. 2018. PMID: 29117996 Free article. Clinical Trial.

2

Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III).

Belonje AM, Voors AA, van Gilst WH, Anker SD, Slart RH, Tio RA, Zijlstra F, van Veldhuisen DJ; HEBE III investigators. Belonje AM, et al. Among authors: voors aa. Am Heart J. 2008 May;155(5):817-22. doi: 10.1016/j.ahj.2007.12.036. Am Heart J. 2008. PMID: 18440327 Clinical Trial.

3

Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.

Hartog JW, Hummel YM, Voors AA, Schalkwijk CG, Miyata T, Huisman RM, Smit AJ, Van Veldhuisen DJ. Hartog JW, et al. Among authors: voors aa. J Card Fail. 2008 Sep;14(7):596-602. doi: 10.1016/j.cardfail.2008.03.008. Epub 2008 May 27. J Card Fail. 2008. PMID: 18722326

4

Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy.

de Jong RM, Tio RA, van der Harst P, Voors AA, Koning PM, Zeebregts CJ, van Veldhuisen DJ, Dierckx RA, Slart RH. de Jong RM, et al. Among authors: voors aa. J Nucl Cardiol. 2009 Sep-Oct;16(5):769-74. doi: 10.1007/s12350-009-9130-9. Epub 2009 Aug 1. J Nucl Cardiol. 2009. PMID: 19649680 Free PMC article.

5

Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial.

Willemsen S, Hartog JW, Hummel YM, Posma JL, van Wijk LM, van Veldhuisen DJ, Voors AA. Willemsen S, et al. Among authors: voors aa. Eur J Heart Fail. 2010 Mar;12(3):294-300. doi: 10.1093/eurjhf/hfp207. Epub 2010 Jan 25. Eur J Heart Fail. 2010. PMID: 20100811 Free article. Clinical Trial.

6

Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).

van der Harst P, Slart RH, Tio RA, Dunselman PH, Willemsen AT, van den Heuvel AF, Voors AA, van Veldhuisen DJ; CORONA Study Group. van der Harst P, et al. Among authors: voors aa. Am J Cardiol. 2010 Feb 15;105(4):517-21. doi: 10.1016/j.amjcard.2009.10.021. Epub 2010 Jan 5. Am J Cardiol. 2010. PMID: 20152247 Clinical Trial.

7

Predictive value of tissue Doppler imaging for left ventricular ejection fraction, remodelling, and infarct size after percutaneous coronary intervention for acute myocardial infarction.

van Melle JP, van der Vleuten PA, Hummel YM, Nijveldt R, Tio RA, Voors AA, Zijlstra F. van Melle JP, et al. Among authors: voors aa. Eur J Echocardiogr. 2010 Aug;11(7):596-601. doi: 10.1093/ejechocard/jeq023. Epub 2010 Mar 7. Eur J Echocardiogr. 2010. PMID: 20211849

8

Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.

Voors AA, van de Wal RM, Hartog JW, Vijn RG, Hummel YM, Plokker TW, van Veldhuisen DJ, Jaarsma W. Voors AA, et al. Cardiovasc Drugs Ther. 2010 Feb;24(1):33-40. doi: 10.1007/s10557-010-6221-4. Cardiovasc Drugs Ther. 2010. PMID: 20229056 Free PMC article. Clinical Trial.

9

A single dose of erythropoietin in ST-elevation myocardial infarction.

Voors AA, Belonje AM, Zijlstra F, Hillege HL, Anker SD, Slart RH, Tio RA, van 't Hof A, Jukema JW, Peels HO, Henriques JP, Ten Berg JM, Vos J, van Gilst WH, van Veldhuisen DJ; HEBE III Investigators. Voors AA, et al. Eur Heart J. 2010 Nov;31(21):2593-600. doi: 10.1093/eurheartj/ehq304. Epub 2010 Aug 29. Eur Heart J. 2010. PMID: 20802250 Clinical Trial.

10

Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients.

Willemsen S, Hartog JW, Hummel YM, van Ruijven MH, van der Horst IC, van Veldhuisen DJ, Voors AA. Willemsen S, et al. Among authors: voors aa. Eur J Heart Fail. 2011 Jan;13(1):76-82. doi: 10.1093/eurjhf/hfq168. Epub 2010 Sep 22. Eur J Heart Fail. 2011. PMID: 20861128 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters